Felix Theeuwes

2013

In 2013, Felix Theeuwes earned a total compensation of $608.1K as Chairman and Chief Scientific Officer at DURECT, a 26% increase compared to previous year.

Compensation breakdown

Option Awards$344,208
Salary$248,221
Other$15,692
Total$608,121

Theeuwes received $344.2K in option awards, accounting for 57% of the total pay in 2013.

Theeuwes also received $248.2K in salary and $15.7K in other compensation.

Rankings

In 2013, Felix Theeuwes' compensation ranked 8,667th out of 12,286 executives tracked by ExecPay. In other words, Theeuwes earned more than 29.5% of executives.

ClassificationRankingPercentile
All
8,667
out of 12,286
30th
Division
Manufacturing
3,149
out of 4,612
32nd
Major group
Chemicals And Allied Products
996
out of 1,462
32nd
Industry group
Drugs
756
out of 1,156
35th
Industry
Pharmaceutical Preparations
601
out of 890
33rd
Source: SEC filing on April 28, 2016.

Theeuwes' colleagues

We found four more compensation records of executives who worked with Felix Theeuwes at DURECT in 2013.

2013

James Brown

DURECT

Chief Executive Officer

2013

Su Yum

DURECT

Executive Vice President, Pharmaceutical Systems R&D

2013

Matthew Hogan

DURECT

Chief Financial Officer

2013

Judy Joice

DURECT

Senior Vice President, Operations and Corporate Quality Assurance

News

In-depth

You may also like